Amarin Corp plc (ADR) (NASDAQ:AMRN)

CAPS Rating: 4 out of 5

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar TMFBiologyFool (95.97) Submitted: 12/3/2010 4:10:04 PM : Outperform Start Price: $5.50 AMRN Score: -127.86

Seems under priced even if ANCHOR fails.

Featured Broker Partners


Advertisement